ISHARES TR - US HLTHCR PR ETF (IHF)

CUSIP: 464288828

Q1 2021 13F Holders as of 31 Mar 2021

Share change
-787,084
Put/Call ratio
15%
SEC-reported price per share
$251.77
Number of holders
180
Value change
-$189,515,930
Number of buys
68
Open additional details 1 more signal available
Number of sells
67

Security key

464288828

Report period

Q1 2021

Institutions

180

Top holders

10

Ownership snapshot

Top reported holders of IHF - ISHARES TR - US HLTHCR PR ETF (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
180
Shares
1,783,288
Rows available
180
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
167
Q1 2021 holders
180
Holder diff
13
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .